Searched for
ICGEB
Govt increases interval between Covishield doses to 12-16 weeks; says the decision is 'science-based'"Based on the available real-life evidences, particularly from the UK, the COVID-19 Working Group agreed for increasing the dosing interval...13 May, 2021, 10.09 PM IST- COVID-19: Research on Mumbai doctors find reinfected patients have worse infectionReinfection of Covid-19 has been confirmed using whole genome sequencing in four healthcare workers from Mumbai. All four have a more sever...23 Sep, 2020, 08.58 AM IST
- 14 vaccine candidates from India look promising: Dr Renu Swarup, Department of BiotechnologyHuman trials for at least 3-4 candidates are likely to begin in the next 2-6 months. Biotechnology Industry Research Investment Council (BI...03 Jun, 2020, 01.15 PM IST
- 'Sweeping generalisations about GMO not fair'Mohanpur (West Bengal), Jan 16 (IANS) Sweeping generalisations about safety of GMOs are "not fair", an eminent scientist said on Monday.16 Jan, 2017, 07.47 PM IST
- 'Research required before low nicotine tobacco adoption'New Delhi, Nov 9 (IANS) There needs to be extensive research on the consequences of adoption of very low nicotine level tobacco on farmers,...09 Nov, 2016, 09.26 PM IST
- Sun Pharma partners ICGEB to develop safer, cheaper dengue vaccineThis is the Mumbai-based company’s second collaboration focussed on the mosquito-borne virus, the first being its pact to develop a botanic...20 Oct, 2016, 12.15 AM IST
- Sun Pharma, ICGEB tie up to develop dengue vaccineSun Pharma will fund and support further development of the vaccine candidate and existing ICGEB knowhow and patents.19 Oct, 2016, 05.50 PM IST
- Why India is struggling to introduce dengue vaccinesThe ICGEB plans a larger vaccine trial on monkeys in America; the full-fledged human trial after that could cost more than Rs 100 crore.09 Oct, 2016, 02.38 PM IST
- Health Ministry panel rejects Sanofi's clinical waiver plea for dengue vaccineThe decision of the apex committee is expected to delay the entry of the vaccine, which has been approved in Mexico, the Philippines and Br...05 May, 2016, 12.48 AM IST
- ICGEB, Sun Pharma tie-up to develop novel dengue drugICGEB and Sun Pharma will develop the drug, known as Cipa, following a registration process that consists of trials and studies that meet b...04 May, 2016, 06.19 PM IST
- Indian scientists develop breakthrough dengue drugxperts are now gearing up for the next step, which is to hold clinical trials and toxicity studies before seeking permission from the Minis...07 Mar, 2016, 05.08 PM IST
- Department of Biotechnology sets up DBT-Pan IIT Centre for BioenergyThe Department of Biotechnology (DBT), ministry of science and technology, has set up the DBT-Pan IIT Centre for Bioenergy, a virtual centr...03 Sep, 2015, 05.17 PM IST
- A biosensor to peer into insides of HIV-infected cellA new biosensor can measure what is going on within HIV-infected cells in real-time & provide insight on the interactions between the AIDS ...15 Dec, 2014, 12.06 PM IST
- A biosensor to peer into insides of HIV-infected cellThis technology can offer insights which can help in controlling the AIDS infection besides insight on the interactions between HIV-1 and T...14 Dec, 2014, 12.37 PM IST
- Cadila Pharmaceuticals and Novavax to develop malaria vaccine using virus like particle technologyCadila Pharma and Novavax to develop new malaria vaccine using VLP technology. ICGEB also to partner them in the project.18 Jul, 2012, 12.20 PM IST
- Corporate India bets big on stem cellThe day may not be too far when India may become a global hub for cure to deadly diseases such as cancer, neurology and cardiac problems. B...02 Feb, 2008, 01.05 PM IST
- ICGEB joins with US based group to develop vaccinesCity-based International Centre for Genetic Engineering and Biotechnology has joined hands with US-based Emory Vaccine Center to develop va...14 Jan, 2008, 08.20 PM IST
Load More
